We investigated the neuroprotective potential of MK-801 (dizocilpine), a noncompetitive N-methyl-D aspartate (NMDA) antagonist, in the setting of three 5-min periods of global cerebral ischemia separated by I-h intervals in halothane-anesthetized rats. Each isch emic insult was produced by bilateral carotid artery oc clusions plus hypotension (50 mm Hg). Brain temperature was maintained at normothermic levels (36.5-37.0°C) throughout the experiment. MK-801 (3 mg/kg) (n = 6) or saline (n = 6) was injected intraperitoneally 45 min fol lowing the end of the first ischemic insult. Following 7-day survival, quantitative neuronal counts of perfusion fixed brains revealed severe ischemic damage in hippo campal CAl area, neocortex, ventrolateral thalamus, and striatum of untreated rats. By contrast, significant pro tection was observed in MK-801-treated rats. In area CAl of the hippocampus, numbers of normal neurons were increased 11-to 14-fold by MK-801 treatment (p < 0.01). The ventrolateral thalamus of MK-801-treated rats It has been well established that repetitive epi sodes of global brain ischemia separated by inter vals of 1 h markedly enhance the extent and inten sity of neuronal injury when compared with equiv alent single periods of ischemia (Mrsulja et aI., 1977; Tomida et aI., 1987; Vass et aI., 1988; Ikeda et aI., 1989; Kato et aI., 1989; Nakano et aI., 1989; Araki et aI., 1990; Hossmann et aI., 1990; Nowak et aI., 1990; Lin et aI., 1992). Glutamate has been pos tulated to play a key role in the pathophysiology of ischemic injury (Rothman and Olney, 1986; Mel-
showed almost complete histologic protection, and neo cortical damage was reduced by 71% (p < 0.01). The degree of MK-801 protection of striatal neurons was less complete than that seen in other vulnerable structures, amounting to 63% for central striatum (p = 0.02, Mann Whitney U test) and 48% in the dorsolateral striatum (NS). A repeated-measures analysis of variance demon strated a highly significant overall protective effect of MK-801 treatment (FI 10 = 37.2, P = 0.0001). These find ings indicate that exc'itotoxic mechanisms play a major role in neuronal damage produced by repeated ischemic insults and that striking cerebroprotection is conferred by MK-801 administered following the first insult in animals with cerebral normothermia. NMDA antagonists may prove useful in patients at risk of repeated episodes of cerebral ischemia. Key Words: Excitotoxicity-N methyl-D-aspartate antagonist-Multiple insults Selective vulnerability. drum, 1989) , and it has been suggested that gluta matergic mechanisms may mediate the enhanced in juriousness of repeated ischemia (Hossmann et al., 1990; Kato et aI., 1990) . Glutamate is massively re leased into the brain's extracellular space during global ischemia and may thereby contribute to in jury (Benveniste et aI., 1984) . We recently reported that multiple ischemic insults lead to massive de layed increases in extracellular glutamate and in the excitotoxic index in the dorsolateral striatum during recirculation-findings not observed following a single ischemic insult (Lin et aI., 1992) . Another recent study has shown that brain hypothermia con fers some protection against multiple ischemic in sults (Lin et aI., 1991) , and other authors have re ported protection following brief ischemia by MK-801 and pentobarbital (Kato et aI., 1990) . In the present study, we employed MK-801, a noncompet-itive N-methyl-D-aspartate (NMDA) antagonist, to assess its pharmacological effect on repeated isch emia and, thereby, to demonstrate whether gluta mate-related excitotoxic mechanisms might con tribute to the process of neuronal injury in repeated ischemia.
MATERIALS AND METHODS

General preparation
Male Wistar rats weighing 250-350 g were used follow ing an overnight fast. Anesthesia was induced with 3% halothane170% nitrous oxide/balance oxygen. The femo ral arteries were cannulated to permit blood pressure measurement and arterial sampling for blood gas deter minations. Rats underwent endotracheal intubation and were mechanically ventilated on 0.5% halothane170% ni trous oxidelbalance oxygen to maintain arterial Peo2 and P02 in the normal range. They were then immobilized with pancuronium bromide, 0.75 mg/kg i.v. Both common carotid arteries were exposed via a midline ventral inci sion and were gently dissected from the surrounding nerve fibers. Ligatures consisting of polyethylene PE-lO tubing contained within double-lumen Silas tic tubing were passed loosely around each artery. Rectal temper ature was measured continually and was maintained at 37.0-37 SC throughout the experiment by a warming lamp above the animal's body. Brain temperature was monitored by a 29-Ga thermocouple implanted stereotax ically in the anterior portion of the left striatum through a small burr hole drilled in the skull. Brain temperature was maintained throughout the experiment at 36.5-37°C by means of a small warming lamp placed above the animal's head. Both rectal and brain temperatures were monitored and regulated until 30 min following the final ischemic insult.
Production of cerebral ischemia
Rats were subjected to three 5-min periods of global cerebral ischemia separated by I-h intervals of normoten sive reperfusion. Prior to each ischemic insult, blood was gradually withdrawn into a heparinized syringe to reduce systemic blood pressure to 50 mm Hg. Cerebral ischemia was then produced by tightening the carotid ligatures bi laterally and maintaining mean blood pressure at 50 mm Hg. To permit postischemic reperfusion, the carotid lig atures were removed and the shed blood was reinfused to restore mean arterial blood pressure to 100-120 mm Hg.
Drug administration
cyclohepten-5,10-imine maleate} was obtained from Re search Biochemicals, Inc. (Natick, MA, U.S.A.). It was dissolved in saline (3 mg/m!) prior to use. Animals receiv ing ischemia were divided into two groups. Group 1 rats (n = 6) received MK-80I, 3 mg/kg i.p., 15 min prior to the second ischemic insult. Group 2 rats (n = 6) received a comparable volume of saline intraperitoneally. A third group of anesthetized rats not subjected to cerebral isch emia served as normal histological controls (n = 5).
Histopathological examination
Seven days following ischemia, rats were reanesthe tized with halothane and were perfused via the ascending aorta with FAM (a mixture of 40% formaldehyde, glacial acetic acid, and methanol, 1: 1:8 by vol) for 19 min at a J Cereb Blood Flow Metab, Vol. 13, No.6, 1993 pressure of lOO-120 mm Hg following a I-min initial per fusion with physiologic saline. The heads were immersed in FAM at 4°C for I day. The brains were then removed and divided into coronal blocks, which were embedded in paraffin. Brain sections, lO f,Lm thick, were prepared at 250-f,Lm intervals. These were stained with hematoxylin and eosin. The neocortex, striatum, hippocampus, and thalamus were examined by observers blinded to the ex perimental conditions. The intensity of ischemic injury was quantitated by counting numbers of necrotic neurons within representative high-power fields of ventrolateral thalamus (400 x), dorsolateral and central striatum (400x), and parietal neocortex immediately dorsal to the entorhinal fissure (lOOx). In the hippocampal CAl sector, numbers of normal pyramidal neurons per 1,000-f,Lm length were counted in the lateral, middle, and medial subsectors.
Statistical analysis
Data are expressed as means ± SD. A one-way analy sis of variance (ANOV A) and, in selected instances (see Results), a Mann-Whitney U test were used to compare neuronal count data in MK-801-treated versus saline treated ischemic rats. A repeated-measures ANOV A (SAS General Linear Models procedures; SAS Systems, Cary, NC, U.S.A.) was used to compare neuronal dam age across all structures in the two ischemic groups. Table 1 summarizes the physiological variables.
RESULTS
Arterial blood gases and mean arterial blood pres sure prior to and following ischemia were generally within the normal range and were similar in MK-80 1-and saline-treated rats. Plasma glucose levels prior to the third ischemic insult were significantly lower in MK-80 1-treated rats than in saline-treated animals (p < 0.05), and there was a statistically in significant trend toward lower plasma glucose val ues in MK-80 1 rats prior to the first two insults (Table 2) . Table 3 shows normal-neuron counts in hippo campal CAl subsectors. In saline-treated rats, nor mal-neuron counts were reduced to 2.9-3.8% of nonischemic control values. Compared with the values of saline-treated ischemic rats, MK-80 1treated rats showed mean increases in normal neuron counts of 14-, 14-, and ll-fold, respectively, in the lateral, middle, and medial CAl subsectors.
These differences were all highly significant (p < 0.0 1, ANOV A). Table 4 summarizes the quantitative data con cerning ischemic injury in the dorsolateral and cen tral striatum, ventrolateral thalamus, and parietal neocortex. Saline-treated rats showed severe injury in each of these structures. By contrast, the vent rolateral thalamus of MK-80 1-treated rats was al most completely protected from ischemic injury (p < 0.0 1, ANOV A), and the degree of neocortical damage was reduced by 71% (p < 0.0 1). Although Values are means ± SD (n).
MK-801 rats showed mean reductions of ischemic neuronal counts of 48 and 63% in dorsolateral and central striatum, respectively, these did not attain statistical significance by ANOV A owing to large variances. By nonparametric analysis (Mann Whitney U test), the intergroup difference in isch emic neuronal count was significant for the central striatum (p = 0.02) but marginal in the case of the dorsolateral striatum (p = 0.07).
A two-factor ANOV A (treatment, structure) was performed with repeated measures on one factor (structure). There was a highly significant between subject effect (Fl,lO = 37.2, P = 0.0001), confirming the great degree of histologic protection conferred by MK-801 treatment. Significant within-subject ef fects were also observed for structure (F6• 60 = 5.43, p = 0.0002) and for structure x treatment interac tion (F6 • 60 = 2.99, P = 0.01). The former denotes variability of histologic injury among the structures analyzed, while the latter is attributable to the dif ferential degree of MK-801-associated cerebropro tection in the various structures (greatest in thala mus and hippocampus, least in dorsolateral stria tum).
Owing to a concern that the lower plasma glucose levels observed in MK-801-treated rats ( Table 2) may have contributed to the cerebroprotection at tributed to this agent, we used linear regression to assess possible correlations between plasma glu cose values and the quantitative neuron data of Ta- 
where ISCH represents the number of ischemic neurons per high-power field of cortex and GLUI and GLU3 are the plasma glucose levels (ml/dl) prior to the first and third insults, respectively. 
DISCUSSION
MK-801, a widely investigated dibenzocycloalk enimine, is a highly potent noncompetitive antago- Values are means ± SD. a Analysis of variance, MK-801-vs. saline-treated rats. Values are means ± SD.
a Analysis of variance, MK-801-vs. saline-treated rats.
nist of NMDA-induced excitotoxicity . It readily crosses the blood-brain barrier and blocks NMDA-activated currents by selectively binding to open ion channels (Wong et al., 1986; Huettner and Bean, 1988) . The present study has shown that MK-801, when first administered 45 min following the first of three 5-min global ischemic insults, markedly protects hippocampal, neocorti cal, and thalamic neurons from ischemic injury and is marginally effective, as well, in the striatum. global ischemic insults. In the latter setting, al though initial reports were positive Rod and Auer, 1989) , subsequent work disclosed prolonged hypothermia in MK-801-treated isch emic animals, which was required for its therapeu tic effect (Buchan and Pulsinelli, 1990; Corbett et al., 1990) . In an extensive study, a protective effect of MK-801 could not be demonstrated in tempera ture-regulated normothermic rats exposed to 5 or 15 min of four-vessel occlusion despite the use of a wide range of MK-801 dosing regimens (Buchan et al., 1991) . We and others have shown that mild de grees of brain hypothermia, by itself, are markedly protective in ischemia (Busto et al., 1987 (Busto et al., , 1989a Minamisawa et al., 1990a,b; Chopp et al., 1991; Ginsberg et al., 1992) and that this is related, at least in part, to the inhibition of glutamate release (Busto J Cereb Blood Flow Metab, Vol. 13, No.6, 1993 et al., 1989b and of ischemia-induced depression of calcium-dependent protein phosphorylation (Churn et al., 1990) , as well as protection against blood brain barrier dysfunction (Dietrich et al., 1990) .
Since brain temperature was monitored only for a 30-min period following the final ischemic insult, a temperature difference between the MK-801treated and untreated groups after this period can not be excluded as an explanation for the present findings.
Intriguingly, it has been in animal models of focal cerebral ischemia that the most convincing evi dence of MK-801 's cerebroprotective efficacy has emerged (Kochhar et al., 1988; Ozyurt et al., 1988; Park et al., 1988a,b; Dirnagl et al., 1990; Bielenberg and Beck, 199 1; Gill et al., 1991; Buchan et al., 1992; Roussel et aI., 1992) . MK-801 also protects against neuronal injury induced by glucose depriva tion in cell culture (Monyer et aI., 1989) and by profound hypoglycemia in normothermic rats (Papagapiou and Auer, 1990) , and it has been re ported to ameliorate tissue edema and ionic dysho meostasis following fluid percussion brain injury in rats (McIntosh et aI., 1990) . MK-80 1 has also proven neuroprotective in neonatal rat models of hypoxic-ischemic brain injury (McDonald et aI., 1987; Hattori et aI., 1989; Olney et aI., 1989) . A factor that distinguishes these settings, and that of focal ischemic brain injury, from global ischemic insults is the greater degree to which cerebral cir culation is preserved in the former situations, allow ing partial maintenance of energy metabolism. It has been recently hypothesized that partial energy failure may be conducive to excitotoxicity mediated by the NMDA receptor complex (Favaron et aI., 1988; Novelli et aI., 1988; Henneberry, 1989; Wie loch et aI., 1989) . Glutamate-induced elevations of intracellular calcium are greatly amplified by meta bolic compromise (Dubinsky and Rothman, 1991) .
In studies in which NMDA or quinolinate, a nat urally occurring NMDA receptor agonist, was in jected into the striatum and hippocampus of rats, MK-801 was found to prevent neurotoxicity even when administered � 1 h following injection of the excitotoxins (Foster et aI., 1988) . These results are consistent with the view that NMDA receptor acti vation does not kill neurons immediately, but rather sets in motion a more protracted process leading eventually to cell death-a process susceptible to antagonism by MK-801. The "self-propagating"
properties of glutamate toxicity have been reviewed previously (Choi and Rothman, 1990) . Other studies in neuronal culture have shown that MK-801 bind ing is possible only when NMDA-operated channels are in a transmitter-activated, "open" state (Huett-FIG. 1. Paraffin-embedded brain sections stained with hematoxylin and eosin from untreated (A-D) and MK-801-treated (E-H) rats 3 days after three 5-min ischemic insults. Micrographs (x 1 ,200) taken from parietal cortex (A, E), CA1 hippocampus (8, F), dorsolateral striatum (C, G), and ventrolateral thalamus (0, H). In untreated specimens, a high frequency of ischemic neurons is detected. In c0ntrast, MK-801 given following the first 5-min insult dramatically attenuates histopathological damage in all brain regions.
ner and Bean, 1988). Low doses of L-glutamate stimulate binding of radiolabeled MK-80 1 to rat brain sections in a regionally selective manner (e.g., medial striatum and septum > cerebral cortex and thalamus) that correlates with the regional selectiv ity of NMDA receptors by radiolabeled glutamate (Monaghan, 1991) . These "agonist-preferring" NMDA receptors are hypothesized to play a greater role in glutamate-mediated toxicity.
A recent study from our laboratory (Lin et al., 1992) (Gill et aI., 1992; Iijima et aI., 1992) and the resulting decrease in extracellular calcium ion concentration (Gill et aI., 1992) . MK-801 also blocks the elevation of cortical intracellular calcium ion, NAD/NADH redox changes, and EEG depres- Vol. 13, No.6, 1993 sion/polyspikes seen after local NMDA superfusion (Uematsu et aI., 1991) . In addition, MK-801 pro duces widespread alterations of local cerebral glu cose metabolism in normal rats (Kurumaji and Mc Culloch, 1989) , induces a lingering suppression of local metabolic activation in response to physiolog ical stimulation (Dietrich et aI., 1989) , inhibits in creased cortical oxygen extraction after middle ce rebral artery occlusion (Chi et aI., 1991) , diminishes postischemic hypoperfusion and promotes blood brain barrier integrity following global ischemia (Stevens and Yaksh, 1990) , and may improve CBF following focal ischemia (Meyer et aI., 1990; Dezsi et aI., 1992) . Finally, MK-801 has been shown to inhibit the activation of the protooncogene c-fos in duced by spreading depression (Herrera and Rob ertson, 1990) or local trauma (Dragunow et aI., 1990) , but, on the other hand, may also induce c-fos protein ) and heat shock protein 72 (Sharp et aI., 1991) . These studies all point to a com plexity of effects, requiring further investigations.
Although plasma glucose levels were lower in MK-801 rats than in saline-treated animals prior to the third ischemic insult of this study, values in both groups were in the normoglycemic range (Table 2) , and regression analysis failed to support a correla tion between glycemic level and neuronal injury to hippocampus, striatum, or thalamus. Thus, it is un likely that the high degree of cerebroprotection ob served in the hippocampus and thalamus of MK-801-treated rats was related to a glucose effect.
However, neuronal injury to the cortex was corre 
